Attention Deficit Hyperactivity Disorder
📧 Sign up to get email alerts when something new happens for Attention Deficit Hyperactivity Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2013-03-01Clinical Trial Update: Evaluation of the Efficacy of Hippotherapy for Children With Developmental Disorders
A completed clinical trial evaluating the efficacy of hippotherapy for children with developmental disorders, including Attention Deficit Hy…
-
CLINICAL_TRIALS trial_result · 2013-02-22Clinical Trial Update: Effectiveness of a Electroencephalogram (EEG) Biofeedback for the Treatment of ADHD [NA]
A completed clinical trial evaluating the effectiveness of EEG biofeedback as a treatment for attention-deficit/hyperactivity disorder.
-
FDA approval · 2013-02-20FDA Approved: INTUNIV — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
FDA approved a supplemental application for INTUNIV (guanfacine) from Takeda Pharmaceuticals America, Inc., marking an update to the product…
-
CLINICAL_TRIALS trial_result · 2013-02-18Clinical Trial Update: Resources to Enhance the Adjustment of Children (REACH) [NA]
The REACH trial conducted by the University of Pittsburgh is reported as completed and appears to study resources to enhance adjustment in c…
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Parent Training to Promote Early Identification and Treatment of Childhood Behavioral Disorders [Phase 3]
The document reports the completion of a Phase 3 trial evaluating a parent-training program to promote early identification and treatment of…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-02-12Clinical Trial Update: Attention-Deficit Hyperactivity Disorder (ADHD) Study With Adults [Phase 3]
A completed Phase 3 clinical trial for attention-deficit/hyperactivity disorder in adults sponsored by GlaxoSmithKline.
-
CLINICAL_TRIALS trial_result · 2013-01-29Clinical Trial Update: A Safety and Efficacy Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 2]
Phase 2 clinical trial assessing safety and efficacy of ABT-089 in children with Attention-Deficit/Hyperactivity Disorder has been completed…
-
CLINICAL_TRIALS trial_result · 2013-01-23Clinical Trial Update: Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adults With ADHD
A completed clinical trial evaluating outcomes of ADHD treatment effectiveness in children and adults.
-
CLINICAL_TRIALS trial_result · 2013-01-21Clinical Trial Update: Long Term Safety and Tolerability Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 2]
Phase 2 long-term safety and tolerability study of ABT-089 in adults with ADHD has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Safety and Tolerability Study of ABT-089 in Children With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 2]
Phase 2 safety and tolerability study of ABT-089 in children with ADHD has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: A Safety and Tolerability Study of ABT-089 in Adults With Attention Deficit-Hyperactivity Disorder (ADHD) [Phase 2]
Phase 2 safety and tolerability study of ABT-089 in adults with ADHD has completed.
-
CLINICAL_TRIALS trial_result · 2013-01-18Clinical Trial Update: Safety, Tolerability and Efficacy Study of ABT-089 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) [Phase 2]
This document reports the completion of a Phase 2 trial evaluating the safety, tolerability, and efficacy of ABT-089 in adults with attentio…
-
FDA approval · 2013-01-17FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (TruPharma, LLC)
FDA approved a supplemental application for clonidine hydrochloride from TruPharma, LLC. This action indicates regulatory approval of a supp…
-
FDA approval · 2013-01-16FDA Approved: CLONIDINE HYDROCHLORIDE — Supplemental Application (Actavis Pharma, Inc.)
The FDA approved a supplemental application for clonidine hydrochloride from Actavis Pharma, Inc., indicating an approved modification to an…
-
FDA approval · 2013-01-11FDA Approved: DURACLON — Supplemental Application (Mylan Institutional LLC)
FDA approved a supplemental application for DURACLON (clonidine hydrochloride) from Mylan Institutional LLC, adding to the existing approved…
-
FDA approval · 2012-12-28FDA Approved: METHYLPHENIDATE HYDROCHLORIDE EXTENDED-RELEASE — Original Application (SpecGx LLC)
FDA approved a generic extended-release methylphenidate hydrochloride product under an original ANDA filed by SpecGx LLC.
-
FDA approval · 2012-12-19FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for methylphenidate hydrochloride from SpecGx LLC, indicating regulatory approval for an existing ge…
-
FDA approval · 2012-12-19FDA Approved: METHYLPHENIDATE HYDROCHLORIDE — Supplemental Application (SpecGx LLC)
FDA approved a supplemental application for methylphenidate hydrochloride from SpecGx LLC. The approval confirms the generic product's appro…
-
CLINICAL_TRIALS research · 2012-12-18Clinical Trial Update: The Relationship of Essential Fatty Acids to Adult ADHD: The OCEAN Study (Oils and Cognitive Effects in Adult ADHD Neurodevelopment) [NA]
A clinical trial investigating whether essential fatty acids affect cognitive function in adults with ADHD, sponsored by King's College Lond…
-
CLINICAL_TRIALS trial_result · 2012-12-12Clinical Trial Update: A Long Term Follow-Up Study for Asian Adult Patients With Attention Deficit Hyperactivity Disorder [Phase 3]
This clinical trial update reports long-term safety and efficacy results from a Phase 3 study of atomoxetine in Asian adults with Attention …
-
CLINICAL_TRIALS trial_result · 2012-12-07Clinical Trial Update: Carnitine as an Adjunct to Methylphenidate for the Treatment of Attention Deficit Hyperactivity Disorder [Phase 2]
Phase 2 clinical trial evaluating whether adding L-carnitine to methylphenidate improves ADHD symptoms; the current status is unknown.
-
CLINICAL_TRIALS trial_result · 2012-11-30Clinical Trial Update: Effects Of The Mindfulness Meditation Practices On Cognition [Phase 3]
A Phase 3 trial evaluating mindfulness meditation practices on cognitive outcomes in individuals with attention-deficit/hyperactivity disord…
-
CLINICAL_TRIALS research · 2012-11-29Clinical Trial Update: Trial to Evaluate the Efficacy of the HLPFC Coil Deep Transcranial Magnetic Stimulation System in Treating Attention Deficit and Hyperactivity Disorder (ADHD) in Adults [NA]
A clinical trial update evaluating the HLPFC Coil Deep Transcranial Magnetic Stimulation System for treating attention deficit hyperactivity…
-
FDA approval · 2012-11-21FDA Approved: METHYLPHENIDATE TRANSDERMAL SYSTEM — Supplemental Application (PADAGIS US LLC)
The FDA approved a supplemental application for the methylphenidate transdermal system (methylphenidate) submitted by PADAGIS US LLC.
-
FDA approval · 2012-11-19FDA Approved: VYVANSE — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
The FDA approved a supplemental application for Vyvanse (lisdexamfetamine dimesylate) submitted by Takeda Pharmaceuticals America, Inc., res…